SCHEMBL28041767

SCHEMBL28041767

CN(Cc1ccccc1)c1ccnc(CC(=O)O)c1

nearest known ligand 0.44

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
IP6K1 Q92551 1/20 0.44
SLC16A3 O15427 1/20 0.43
SLC16A1 P53985 1/20 0.43
NR1H2 P55055 2/20 0.42
NR1H3 Q13133 2/20 0.42
HDAC1 Q13547 2/20 0.42
L3MBTL1 Q9Y468 1/20 0.40
NPC1 O15118 2/20 0.40
RAB9A P51151 2/20 0.40
CA12 O43570 1/20 0.40
CA9 Q16790 1/20 0.40
AKR1B1 P15121 1/20 0.40
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
DHFR P00374 1/20 0.39
HDAC3 O15379 1/20 0.39
DHODH Q02127 1/20 0.38
KDM5B Q9UGL1 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14876436 0.80 KDM4E (0.62) IP6K1SLC16A3SLC16A1NR1H2NR1H3
SCHEMBL28097365 0.77 IP6K1 (0.42) IP6K1SLC16A3SLC16A1RAB9AMEN1
SCHEMBL28041765 0.76 IP6K1 (0.43) IP6K1SLC16A3SLC16A1HDAC1NPC1
SCHEMBL14876216 0.76 KDM4E (0.46) IP6K1SLC16A3SLC16A1HDAC1L3MBTL1
SCHEMBL14876210 0.76 ALDH1A1 (0.46) IP6K1SLC16A3SLC16A1NR1H2NR1H3
SCHEMBL5314271 0.75 IP6K1 (0.46) IP6K1SLC16A3SLC16A1NR1H2NR1H3
SCHEMBL27966141 0.74 HSP90AA1 (0.44) L3MBTL1AKR1B1KDM5B
Hydrochloric Acid SCHEMBL14812774 0.73 AKR1B1 (0.57) SLC16A3SLC16A1NR1H2NR1H3HDAC1
SCHEMBL5182572 0.70 NR1H2 (0.50) NR1H2NR1H3HDAC1HDAC3
SCHEMBL27532059 0.69 POLB (0.51) L3MBTL1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103958475-B Heteroaryl hydroxamic acid derivatives and their use in the treatment, alleviation or prevention of viral diseases F. HOFFMANN-LA ROCHE AG (CH) 2015-11-25 CN disclosed
CN-103958521-A Pyrimidin-4-one derivatives and their use in the treatment, alleviation or prevention of viral diseases HOFFMANN LA ROCHE 2014-07-30 CN disclosed
CN-103958475-A Heteroaryl hydroxamic acid derivatives and their use in the treatment, alleviation or prevention of viral diseases HOFFMANN LA ROCHE 2014-07-30 CN disclosed